Literature DB >> 23423417

Clinical outcomes associated with procalcitonin algorithms to guide antibiotic therapy in respiratory tract infections.

Philipp Schuetz1, Matthias Briel, Beat Mueller.   

Abstract

CLINICAL QUESTION: In patients with respiratory tract infection, is measurement of procalcitonin to guide antibiotic prescriptions associated with reduced antibiotic exposure without increases in all-cause mortality or treatment failure? BOTTOM LINE: The measurement of procalcitonin to guide initiation and duration of antibiotic treatment in patients with respiratory tract infections of varying severity is associated with lower antibiotic exposure without increasing all-cause mortality or treatment failure.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23423417     DOI： 10.1001/jama.2013.697

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


  28 in total

1.  Comparison of serum procalcitonin in respiratory infections and bloodstream infections.

Authors:  Yanhui Zhu; Yulin Yuan; Huayi Huang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Clinical outcomes and costs associated with procalcitonin utilization in hospitalized patients with pneumonia, heart failure, viral respiratory infection, or chronic obstructive pulmonary disease.

Authors:  Stacy Aric Johnson; Austin Bernard Rupp; Kirsten Leigh Rupp; Santosh Reddy
Journal:  Intern Emerg Med       Date:  2021-01-16       Impact factor: 3.397

3.  Biomarker-guided de-escalation of empirical therapy is associated with lower risk for adverse outcomes.

Authors:  Philipp Schuetz; Beat Mueller
Journal:  Intensive Care Med       Date:  2013-10-30       Impact factor: 17.440

4.  Procalcitonin as an Early Marker of the Need for Invasive Respiratory or Vasopressor Support in Adults With Community-Acquired Pneumonia.

Authors:  Wesley H Self; Carlos G Grijalva; Derek J Williams; Alison Woodworth; Robert A Balk; Sherene Fakhran; Yuwei Zhu; D Mark Courtney; James Chappell; Evan J Anderson; Chao Qi; Grant W Waterer; Christopher Trabue; Anna M Bramley; Seema Jain; Kathryn M Edwards; Richard G Wunderink
Journal:  Chest       Date:  2016-04-21       Impact factor: 9.410

5.  Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States.

Authors:  Robert A Balk; Sameer S Kadri; Zhun Cao; Scott B Robinson; Craig Lipkin; Samuel A Bozzette
Journal:  Chest       Date:  2016-08-25       Impact factor: 9.410

6.  Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis.

Authors:  Brendan J Kelly; Ebbing Lautenbach; Irving Nachamkin; Susan E Coffin; Jeffrey S Gerber; Barry D Fuchs; Charles Garrigan; Xiaoyan Han; Warren B Bilker; Jacqueleen Wise; Pam Tolomeo; Jennifer H Han
Journal:  Diagn Microbiol Infect Dis       Date:  2016-01-08       Impact factor: 2.803

7.  Antibiotic utilization for acute respiratory tract infections in U.S. emergency departments.

Authors:  John P Donnelly; John W Baddley; Henry E Wang
Journal:  Antimicrob Agents Chemother       Date:  2013-12-16       Impact factor: 5.191

8.  Procalcitonin as a Decision-Supporting Marker of Urgent Biliary Decompression in Acute Cholangitis.

Authors:  Yoon Suk Lee; Kwang Bum Cho; Kyung Sik Park; Ju Yup Lee; Yoo Jin Lee
Journal:  Dig Dis Sci       Date:  2018-02-26       Impact factor: 3.199

9.  Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational Study.

Authors:  Theodoros Kelesidis; Nikolay Braykov; Daniel Z Uslan; Daniel J Morgan; Sumanth Gandra; Birgir Johannsson; Marin L Schweizer; Scott A Weisenberg; Heather Young; Joseph Cantey; Eli Perencevich; Edward Septimus; Arjun Srinivasan; Ramanan Laxminarayan
Journal:  Infect Control Hosp Epidemiol       Date:  2015-10-12       Impact factor: 3.254

10.  Optimizing triage and hospitalization in adult general medical emergency patients: the triage project.

Authors:  Philipp Schuetz; Pierre Hausfater; Devendra Amin; Sebastian Haubitz; Lukas Fässler; Eva Grolimund; Alexander Kutz; Ursula Schild; Zeljka Caldara; Katharina Regez; Andriy Zhydkov; Timo Kahles; Krassen Nedeltchev; Stefanie von Felten; Sabina De Geest; Antoinette Conca; Petra Schäfer-Keller; Andreas Huber; Mario Bargetzi; Ulrich Buergi; Gabrielle Sauvin; Pasqualina Perrig-Chiello; Barbara Reutlinger; Beat Mueller
Journal:  BMC Emerg Med       Date:  2013-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.